Cryoablation, Radiofrequency Ablation, and Laser Ablation for Treatment of Chronic Rhinitis

This policy addresses minimally invasive posterior nasal nerve ablation procedures—cryoablation, radiofrequency ablation, and laser ablation—intended to treat adults (≥18 years) with chronic allergic or nonallergic rhinitis (rhinorrhea ± congestion) that is refractory to adequate medical therapy. Major limitations: the procedures are considered experimental/investigational and are not covered or recommended as first‑line therapy, FDA clearance is limited (e.g., 510(k) for some cryotherapy devices and no FDA‑cleared laser devices for rhinitis), and use is generally reserved for patients who have failed medical management or within randomized clinical trials.

"Refractory chronic rhinitis (allergic, nonallergic, or mixed) with persistent symptoms despite adequate medical therapy"

Sign up to see full coverage criteria, indications, and limitations.